Literature DB >> 29941425

A Genetic Determinant of Persister Cell Formation in Bacterial Pathogens.

David R Cameron1, Yue Shan1, Eliza A Zalis1, Vincent Isabella1, Kim Lewis2.   

Abstract

Persisters represent a small subpopulation of cells within a bacterial culture that are tolerant to killing by antibiotics. Persisters have been linked to recalcitrant infections caused by numerous bacterial pathogens, including Pseudomonas aeruginosa A classic example is the incurable infection of the airways for patients with cystic fibrosis. The genetic mediators of persister formation for P. aeruginosa are poorly understood. We generated a high-density transposon insertion library of P. aeruginosa PAO1 and determined the relative frequency of each insertion following fluoroquinolone treatment using transposon sequencing (Tn-seq). Of the 4,411 disrupted genes included in the screen, 137 had a ≥10-fold impact on survival. The gene disruption that resulted in the lowest survival rate was disruption of carB, which codes for the large subunit of carbamoyl phosphate synthetase (CPSase). CPSase is a metabolic enzyme that is involved in pyrimidine and arginine synthesis. Disruption of carB resulted in survival rates that were reduced by up to 2,500-fold following antibiotic treatment, and this phenotype was abolished by the addition of uracil, highlighting the importance of de novo pyrimidine biosynthesis for persister formation. Disruption of carB resulted in intracellular ATP accumulation, and lowering ATP levels using arsenate restored the antibiotic tolerance profile of the mutant to levels similar to those seen with the wild type. A decrease in ATP would lead to reduced antibiotic target activity and increased survival.IMPORTANCE Antibiotic treatment of P. aeruginosa residing in the lung of cystic fibrosis patients is ineffective. Treatment failure is attributed in part to antibiotic-tolerant phenotypic variants known as persister cells. Understanding how these cells emerge will likely inform future therapeutic strategies. In the current study, we identified carB, which codes for the large subunit of carbamoyl-phosphate synthetase, as a persister gene that contributes to multidrug tolerance in P. aeruginosa Disruption of carB resulted in a metabolic perturbation that increased cellular ATP and reduced persister formation. Conversely, lowering ATP in the mutant restored antibiotic tolerance. Our data support the hypothesis that a drop in intracellular ATP is a general mechanism of persister formation in bacteria.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  Tn-seq; antibiotic tolerance; persisters

Mesh:

Substances:

Year:  2018        PMID: 29941425      PMCID: PMC6088157          DOI: 10.1128/JB.00303-18

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  47 in total

1.  Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment.

Authors:  Robert E. W. Hancock; David P. Speert
Journal:  Drug Resist Updat       Date:  2000-08       Impact factor: 18.500

Review 2.  Mechanisms of action of antimicrobials: focus on fluoroquinolones.

Authors:  D C Hooper
Journal:  Clin Infect Dis       Date:  2001-03-15       Impact factor: 9.079

Review 3.  Mechanism of bactericidal action of aminoglycosides.

Authors:  B D Davis
Journal:  Microbiol Rev       Date:  1987-09

4.  Contribution of the MexX-MexY-oprM efflux system to intrinsic resistance in Pseudomonas aeruginosa.

Authors:  N Masuda; E Sakagawa; S Ohya; N Gotoh; H Tsujimoto; T Nishino
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

5.  Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli.

Authors:  Tobias Dörr; Marin Vulić; Kim Lewis
Journal:  PLoS Biol       Date:  2010-02-23       Impact factor: 8.029

6.  Molecular cloning of the plasmid RP4 primase region in a multi-host-range tacP expression vector.

Authors:  J P Fürste; W Pansegrau; R Frank; H Blöcker; P Scholz; M Bagdasarian; E Lanka
Journal:  Gene       Date:  1986       Impact factor: 3.688

7.  Role of global regulators and nucleotide metabolism in antibiotic tolerance in Escherichia coli.

Authors:  Sonja Hansen; Kim Lewis; Marin Vulić
Journal:  Antimicrob Agents Chemother       Date:  2008-06-02       Impact factor: 5.191

8.  Activated ClpP kills persisters and eradicates a chronic biofilm infection.

Authors:  B P Conlon; E S Nakayasu; L E Fleck; M D LaFleur; V M Isabella; K Coleman; S N Leonard; R D Smith; J N Adkins; K Lewis
Journal:  Nature       Date:  2013-11-13       Impact factor: 49.962

9.  Persisters: a distinct physiological state of E. coli.

Authors:  Devang Shah; Zhigang Zhang; Arkady Khodursky; Niilo Kaldalu; Kristi Kurg; Kim Lewis
Journal:  BMC Microbiol       Date:  2006-06-12       Impact factor: 3.605

10.  Genetic basis of persister tolerance to aminoglycosides in Escherichia coli.

Authors:  Yue Shan; David Lazinski; Sarah Rowe; Andrew Camilli; Kim Lewis
Journal:  MBio       Date:  2015-04-07       Impact factor: 7.867

View more
  21 in total

Review 1.  (p)ppGpp and Its Role in Bacterial Persistence: New Challenges.

Authors:  Olga Pacios; Lucia Blasco; Inés Bleriot; Laura Fernandez-Garcia; Antón Ambroa; María López; German Bou; Rafael Cantón; Rodolfo Garcia-Contreras; Thomas K Wood; Maria Tomás
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

2.  Mutant Strains of Escherichia coli and Methicillin-Resistant Staphylococcus aureus Obtained by Laboratory Selection To Survive on Metallic Copper Surfaces.

Authors:  Pauline Bleichert; Lucy Bütof; Christian Rückert; Martin Herzberg; Romeu Francisco; Paula V Morais; Gregor Grass; Jörn Kalinowski; Dietrich H Nies
Journal:  Appl Environ Microbiol       Date:  2020-12-17       Impact factor: 4.792

3.  Molecular reprogramming and phenotype switching in Staphylococcus aureus lead to high antibiotic persistence and affect therapy success.

Authors:  Markus Huemer; Srikanth Mairpady Shambat; Judith Bergada-Pijuan; Sandra Söderholm; Mathilde Boumasmoud; Clément Vulin; Alejandro Gómez-Mejia; Minia Antelo Varela; Vishwachi Tripathi; Sandra Götschi; Ewerton Marques Maggio; Barbara Hasse; Silvio D Brugger; Dirk Bumann; Reto A Schuepbach; Annelies S Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-16       Impact factor: 11.205

4.  High level of persister frequency in clinical staphylococcal isolates.

Authors:  Sarita Manandhar; Anjana Singh; Ajit Varma; Shanti Pandey; Neeraj Shrivastava
Journal:  BMC Microbiol       Date:  2022-04-21       Impact factor: 3.605

5.  Mutation to ispA Produces Stable Small-Colony Variants of Pseudomonas aeruginosa That Have Enhanced Aminoglycoside Resistance.

Authors:  Yok-Ai Que; David R Cameron; Melissa Pitton; Simone Oberhaensli; Fiona Appiah; Jean-Luc Pagani; Anne Fournier; Stephan M Jakob
Journal:  Antimicrob Agents Chemother       Date:  2022-07-05       Impact factor: 5.938

6.  The Role of PaFicT in Pseudomonas aeruginosa Persister Cell Formation.

Authors:  Dawson Fogen
Journal:  Int J Mol Cell Med       Date:  2022-06-06

7.  Bacterial defenses against a natural antibiotic promote collateral resilience to clinical antibiotics.

Authors:  Lucas A Meirelles; Elena K Perry; Megan Bergkessel; Dianne K Newman
Journal:  PLoS Biol       Date:  2021-03-10       Impact factor: 8.029

8.  Transcriptional Diversity and Niche-Specific Distribution of Leukocyte Populations during Staphylococcus aureus Craniotomy-Associated Biofilm Infection.

Authors:  Amy L Aldrich; Christopher M Horn; Cortney E Heim; Lee E Korshoj; Tammy Kielian
Journal:  J Immunol       Date:  2021-01-08       Impact factor: 5.422

9.  Genome-Wide Identification of Pseudomonas aeruginosa Genes Important for Desiccation Tolerance on Inanimate Surfaces.

Authors:  Sardar Karash; Timothy L Yahr
Journal:  mSystems       Date:  2022-04-26       Impact factor: 7.324

10.  Deacylated tRNA Accumulation Is a Trigger for Bacterial Antibiotic Persistence Independent of the Stringent Response.

Authors:  Whitney N Wood; Kyle Mohler; Jesse Rinehart; Michael Ibba
Journal:  mBio       Date:  2021-06-15       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.